Biology Reference
In-Depth Information
3. Carroll MW, Moss B (1997) Host range and cytopathogenicity of the highly
attenuated MVA strain of vaccinia virus: propagation and generation of recom-
binant viruses in a nonhuman mammalian cell line. Virology 238: 198-211.
4. Okeke MI, Nilssen O, Traavik T (2006) Modified vaccinia virus Ankara multi-
plies in rat IEC-6 cells and limited production of mature virions occurs in other
mammalian cell lines. J Gen Virol 87: 21-27.
5. Antoine G, Scheiflinger F, Dorner F, Falkner FG (1998) The complete genomic
sequence of the modified vaccinia Ankara strain: comparison with other or-
thopoxviruses. Virology 244: 365-396.
6. Haga IR, Bowie AG (2005) Evasion of innate immunity by vaccinia virus.
Parasitology 130 SupplS11-25.
7. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, et al. (2003)
Poxviruses and immune evasion. Annu Rev Immunol 21: 377-423.
8. Webb LM, Alcami A (2005) Virally encoded chemokine binding proteins. Mini
Rev Med Chem 5: 833-848.
9. Wyatt LS, Carroll MW, Czerny CP, Merchlinsky M, Sisler JR, et al. (1998)
Marker rescue of the host range restriction defects of modified vaccinia virus
Ankara. Virology 251: 334-342.
10. Sutter G, Wyatt LS, Foley PL, Bennink JR, Moss B (1994) A recombinant vec-
tor derived from the host range-restricted and highly attenuated MVA strain
of vaccinia virus stimulates protective immunity in mice to influenza virus.
Vaccine 12: 1032-1040.
11. Gomez CE, Rodriguez D, Rodriguez JR, Abaitua F, Duarte C, et al. (2001)
Enhanced CD8+ T cell immune response against a V3 loop multi-epitope
polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein
and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a
comparison of humoral and cellular immune responses with the vaccinia virus
Western Reserve (WR) vector. Vaccine 20: 961-971.
12. Hirsch VM, Fuerst TR, Sutter G, Carroll MW, Yang LC, et al. (1996) Patterns
of viral replication correlate with outcome in simian immunodeficiency virus
(SIV)-infected macaques: effect of prior immunization with a trivalent SIV vac-
cine in modified vaccinia virus Ankara. J Virol 70: 3741-3752.
13. Ramirez JC, Gherardi MM, Esteban M (2000) Biology of attenuated modified
vaccinia virus Ankara recombinant vector in mice: virus fate and activation of
B- and T-cell immune responses in comparison with the Western Reserve strain
and advantages as a vaccine. J Virol 74: 923-933.
Search WWH ::
Custom Search